BIOLUX P-IV CHINA ( BIOTRONIK )
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT02912715
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 158 participants
- Registry
-
NCT02912715
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02912715. Allocation not applicable; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2020-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BIOLUX P-IV CHINA ( BIOTRONIK )
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Paclitaxel releasing angioplasty balloon
- Lead sponsor
- Biotronik (Beijing) Medical Device Ltd.
Record details
- Record id
cardio:ct-nct02912715- Content hash
46d57e2adce167eb22e8d70a4827e286aae7fd90437a14b77efd441cd4f7b67c